DE60017250D1 - Synergistische zusammensetzung zur krebsbehandlung - Google Patents

Synergistische zusammensetzung zur krebsbehandlung

Info

Publication number
DE60017250D1
DE60017250D1 DE60017250T DE60017250T DE60017250D1 DE 60017250 D1 DE60017250 D1 DE 60017250D1 DE 60017250 T DE60017250 T DE 60017250T DE 60017250 T DE60017250 T DE 60017250T DE 60017250 D1 DE60017250 D1 DE 60017250D1
Authority
DE
Germany
Prior art keywords
cancer treatment
synergistic composition
synergistic
composition
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60017250T
Other languages
English (en)
Inventor
Cristina Geroni
Marina Ripamonti
Michele Caruso
Antonino Suarato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of DE60017250D1 publication Critical patent/DE60017250D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60017250T 1999-02-25 2000-01-31 Synergistische zusammensetzung zur krebsbehandlung Expired - Fee Related DE60017250D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904386.1A GB9904386D0 (en) 1999-02-25 1999-02-25 Antitumour synergistic composition
PCT/EP2000/000746 WO2000050033A2 (en) 1999-02-25 2000-01-31 Anti-tumor synergetic composition

Publications (1)

Publication Number Publication Date
DE60017250D1 true DE60017250D1 (de) 2005-02-10

Family

ID=10848513

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60017250T Expired - Fee Related DE60017250D1 (de) 1999-02-25 2000-01-31 Synergistische zusammensetzung zur krebsbehandlung

Country Status (17)

Country Link
US (1) US6593303B1 (de)
EP (1) EP1169035B1 (de)
JP (1) JP2002537334A (de)
KR (1) KR20010102402A (de)
CN (1) CN1341020A (de)
AR (1) AR022719A1 (de)
AT (1) ATE286391T1 (de)
AU (1) AU774393B2 (de)
BR (1) BR0008454A (de)
CA (1) CA2361828A1 (de)
DE (1) DE60017250D1 (de)
GB (1) GB9904386D0 (de)
HK (1) HK1042249A1 (de)
MY (1) MY125222A (de)
NZ (1) NZ513352A (de)
WO (1) WO2000050033A2 (de)
ZA (1) ZA200106210B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9916882D0 (en) * 1999-07-19 1999-09-22 Pharmacia & Upjohn Spa Antitumor synergistic composition
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
DE602006013810D1 (de) 2005-04-22 2010-06-02 Mitsubishi Chem Corp Aus biomasseressourcen gewonnener polyester und herstellungsverfahren dafür

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
JPH02157291A (ja) * 1988-12-07 1990-06-18 Morishita Pharmaceut Co Ltd アントラサイクリン系抗生物質のｎ−ホルミルアミノ酸複合体およびその白金錯体組成物
GB9114549D0 (en) * 1991-07-05 1991-08-21 Erba Carlo Spa Mono and bis alkylamino-anthracyclines
US5294538A (en) 1991-11-18 1994-03-15 Cold Spring Harbor Labs. Method of screening for antimitotic compounds using the CDC25 tyrosine phosphatase
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
GB9325417D0 (en) * 1993-12-13 1994-02-16 Erba Carlo Spa 3'- aziridino-anthracycline derivatives
JPH07188034A (ja) * 1993-12-28 1995-07-25 Nisshin Flour Milling Co Ltd エンドセリン変換酵素阻害剤
KR100365171B1 (ko) * 1994-08-08 2003-02-19 드바이오팜 에스.아. 약학적으로안정한옥살리플라티늄제제
US5919816A (en) * 1994-11-14 1999-07-06 Bionumerik Pharmaceuticals, Inc. Formulations and methods of reducing toxicity of antineoplastic agents
JP4172726B2 (ja) * 1996-05-22 2008-10-29 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド シス―ドコサヘキサエン酸とドセタキセルとの共有複合体を含有する製剤
WO1999062551A1 (en) * 1998-06-05 1999-12-09 Board Of Regents, The University Of Texas System Texaphyrin conjugates and uses thereof

Also Published As

Publication number Publication date
BR0008454A (pt) 2002-01-29
EP1169035A2 (de) 2002-01-09
JP2002537334A (ja) 2002-11-05
CA2361828A1 (en) 2000-08-31
ZA200106210B (en) 2002-10-28
KR20010102402A (ko) 2001-11-15
WO2000050033A3 (en) 2000-12-21
WO2000050033A2 (en) 2000-08-31
ATE286391T1 (de) 2005-01-15
AU774393B2 (en) 2004-06-24
AU2668100A (en) 2000-09-14
AR022719A1 (es) 2002-09-04
HK1042249A1 (zh) 2002-08-09
MY125222A (en) 2006-07-31
US6593303B1 (en) 2003-07-15
GB9904386D0 (en) 1999-04-21
CN1341020A (zh) 2002-03-20
NZ513352A (en) 2003-08-29
EP1169035B1 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
ATE279190T1 (de) Synergistische zusammensetzungen zur krebsbehandlung
ATE430570T1 (de) Synergistische kombinationstherapie zur krebsbehandlung
AU6147401A (en) Compositions and methods for the treatment of cancer
GB0401948D0 (en) Topical composition for treating pain
ATE326842T1 (de) Zusammensetzung zur saatgutbehandlung
DK1250152T3 (da) Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
DE60223576D1 (de) Hautbehandlungszusammensetzung
EP1461047A4 (de) Zusammensetzungen und verfahren zur behandlung von tieren
DE60111520D1 (de) Hydroxyphenyl-piperazinyl-methyl-benzamid-derivate zur schmerzbehandlung
ATE403438T1 (de) Immuntherapeutische kombinationen zur tumorbehandlung
DE60042606D1 (de) Anti-angiogener zellulärer wirkstoff zur krebsbehanldung
DE10081194D2 (de) Darreichungsform zur Applikation in Körperöffnungen
HUP0500199A2 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
GB2354944B (en) Skin treatment compositions
ATE286391T1 (de) Synergistische zusammensetzung zur krebsbehandlung
GB0026015D0 (en) Cancer treatment
IL148815A0 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer
HU9902296D0 (en) Pharmaceutical composition for treating caltification
AU2002360454A8 (en) Methods and compositions for treating cancer
SI2105135T1 (sl) Farmacevtski sestavki za zdravljenje raka
LV12535A (lv) Treatment having antioxidant effect for stregthening capillars
GB9917160D0 (en) Maldour treatment compositions
NO995276D0 (no) Behandlingsbenk
IL131335A0 (en) Emulsions for cancer treatment

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee